论文部分内容阅读
目的探讨米非司酮配伍米索前列醇治疗瘢痕子宫宫内残留物的临床疗效。方法将2010年1月～2010年12月收治44例各种难治宫内残留患者,随机分为观察组和对照组,对照组在抗炎治疗后行清宫术,观察组采用米非司酮配伍米索前列醇治疗后行清宫术,比较两组临床疗效。结果观察组术中宫颈松弛率100%,腹痛者0例,出血量为(45±15)mL,宫内残留0例,疗效显著优于对照组(P<0.05)。结论米非司酮配伍米索前列醇治疗瘢痕子宫宫内残留物临床疗效较好,且操作简单有效,可降低清宫术的并发症。
Objective To investigate the clinical efficacy of mifepristone combined with misoprostol in the treatment of uterine uterine residue in scars. Methods From January 2010 to December 2010, 44 patients with intrauterine residual refractory to various intrauterine diseases were enrolled and randomly divided into observation group and control group. The control group underwent curettage after anti-inflammatory treatment. The observation group was treated with mifepristone Compatibility misoprostol after radical curettage, the clinical efficacy of two groups were compared. Results In the observation group, the cervical relaxation rate was 100%, the abdominal pain was 0, the bleeding volume was (45 ± 15) mL and the intrauterine residue was 0. The curative effect was significantly better than that of the control group (P <0.05). Conclusion The combination of mifepristone and misoprostol in the treatment of uterine uterine residue in the clinical curative effect is good, and the operation is simple and effective, can reduce the complications of curettage.